eMedicine Specialties > Emergency Medicine > Infectious Diseases

Schistosomiasis: Differential Diagnoses & Workup

Author: Amy J Behrman, MD, Associate Professor, Department of Emergency Medicine, Director, Division of Occupational Medicine, University of Pennsylvania School of Medicine
Contributor Information and Disclosures

Updated: Apr 2, 2008

Differential Diagnoses

Congestive Heart Failure and Pulmonary Edema
Spinal Cord Infections
Gastroenteritis
Urinary Obstruction
Inflammatory Bowel Disease
Urinary Tract Infection, Female
Salmonella Infection
Urinary Tract Infection, Male
Serum Sickness

Other Problems to Be Considered

Cirrhosis
Pulmonary hypertension
Co-infection with malaria
Co-infection with HIV
Co-infection with hepatitis B or hepatitis C

Workup

Laboratory Studies

  • Blood tests are occasionally useful in supporting the diagnosis or assessing the severity of schistosomal infection. Serologies, and, more recently, polymerase chain reaction (PCR) – based testing can confirm a diagnosis.2,3
  • A complete blood cell (CBC) count may reveal peripheral eosinophilia, particularly in acute infection, anemia, or both.
  • Chemistries  
    • Increased alkaline phosphatase level and gamma-glutamyltransferase (GGT) level are observed with hepatic granulomatosis.
    • Transaminase levels generally are not affected, and elevations are usually caused by coexisting hepatitis.
    • Renal function may be decreased if obstructive nephropathy is severe.
  • Blood cultures are indicated for patients with persistent or recurrent fever and for those who may have developed recurrent salmonellal infection with severe enteric schistosomiasis.
  • Urine microbiology is key when diagnosing vesicular infection from S haematobium. Gross and microscopic hematuria is common. Concentration methods may be necessary, and a rough determination of egg-load can be obtained. However, this should not be used as a firm measure of disease severity as egg counts can vary markedly between specimens in one patient.
  • Fecal microbiology, usually on thick smears, is key when diagnosing schistosomiasis with primary bowel infection. Stool specimens may be positive for heme or grossly bloody. Concentration methods will be needed to identify light infestations. Rough quantitation can also be performed in these specimens with the same limitations as above.

Imaging Studies

  • Ultrasonography 
    • Ultrasonography (US) is a sensitive means of assessing hepatosplenic disease with periportal fibrosis or urinary obstruction.
    • It can demonstrate periportal fibrosis, splenomegaly, portal collaterals, periportal adenopathy, ureteral obstruction, and obstructive nephropathy.
  • Echocardiography can demonstrate pulmonary hypertension and cor pulmonale, if present.
  • Chest radiographs may show patchy infiltrates in acute schistosomiasis and can indicate pulmonary hypertension and cor pulmonale in end-stage chronic infection, if present.
  • CT scanning may be useful in the evaluation of CNS disease or in the detection of periportal fibrosis.
  • Magnetic resonance imaging (MRI) may be useful in the evaluation of CNS disease or in the detection of periportal fibrosis.

Other Tests

  • Serology  
    • Enzyme-linked immunosorbent assay (ELISA) testing is available and can be helpful to confirm past exposure. However, antibody testing cannot distinguish active infection from inactive infection.
    • The use of schistosomal antigen testing to help distinguish between active and inactive infection is promising but unlikely to assist in emergency management.
    • Antigen titers from serum and urine correlate with the degree of infection, as indicated by concomitant egg counts.
    • These tests may be particularly useful during acute or end-stage disease, when egg shedding can be minimal.
  • Microscopy  
    • The finding of schistosomal eggs in the urine supports a definitive diagnosis.
    • Urine samples can be examined qualitatively after centrifuging. However, eggs are not shed at a steady rate during the day, and quantitative egg counts are useful for determining the degree of infestation and response to therapy. Therefore, 24-hour urine collections may be recommended.
    • The finding of schistosomal eggs in the stool supports a definitive diagnosis.
    • Stool specimens usually are examined in a thick smear clarified with glycerol (Kato-Katz technique). Schistosomal species can be distinguished using egg morphology.
    • Microscopy is not part of a standard ova and parasite evaluation and must be ordered specifically.
    • Quantitative evaluation allows assessment of the degree of infection and treatment response.
    • Hatching assays may be performed on fresh stool specimens to distinguish active from treated infection because dead eggs may be shed for up to 1 year after treatment.

Procedures

  • Colonic biopsy  
    • Use of multiple crush specimens from the colon and/or rectum to visualize parasite eggs is a sensitive and specific test for enteric schistosomiasis.
    • In the United States, where schistosomiasis is rare, most cases are diagnosed by this method.
  • Cystoscopy may be useful in schistosomiasis with primary bladder involvement for definitive diagnosis or to evaluate secondary ulcers and polyps, biopsy for malignancy, rule out other sources of hematuria and dysuria, and identify eggs in mucosal biopsy specimens.
  • Endoscopy and sclerotherapy may be indicated emergently in the presence of hematemesis caused by portal hypertension.
  • Liver biopsy may be appropriate in patients with unclear diagnoses or suspected co-infections.

More on Schistosomiasis

Overview: Schistosomiasis
Differential Diagnoses & Workup: Schistosomiasis
Treatment & Medication: Schistosomiasis
Follow-up: Schistosomiasis
References

References

  1. Vennervald BJ, Dunne DW. Morbidity in schistosomiasis: an update. Curr Opin Infect Dis. Oct 2004;17(5):439-47. [Medline].

  2. Lier T, Simonsen GS, Haaheim H, Hjelmevoll SO, Vennervald BJ, Johansen MV. Novel real-time PCr for detection of Schistosoma japonicum in stool. Southeast Asian J Trop Med Public Health. Mar 2006;37(2):257-64. [Medline].

  3. Sandoval N, Siles-Lucas M, Pérez-Arellano JL, Carranza C, Puente S, López-Abán J. A new PCR-based approach for the specific amplification of DNA from different Schistosoma species applicable to human urine samples. Parasitology. Nov 2006;133(Pt 5):581-7. [Medline].

  4. Utzinger J, Xiao SH, Tanner M, Keiser J. Artemisinins for schistosomiasis and beyond. Curr Opin Investig Drugs. Feb 2007;8(2):105-16. [Medline].

  5. Xiao SH, Keiser J, Chollet J, Utzinger J, Dong Y, Endriss Y. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrob Agents Chemother. Apr 2007;51(4):1440-5. [Medline].

  6. Badmos KB, Komolafe AO, Rotimi O. Schistosomiasis presenting as acute appendicitis. East Afr Med J. Oct 2006;83(10):528-32. [Medline].

  7. Bahrami S, Alatassi H, Slone SP, O'Connor DM. Tubal gestation and schistosomiasis: a case report. J Reprod Med. Jul 2006;51(7):595-8. [Medline].

  8. Bezerra AS, D'Ippolito G, Caldana RP, Cecin AO, Ahmed M, Szejnfeld J. Chronic hepatosplenic schistosomiasis mansoni: magnetic resonance imaging and magnetic resonance angiography findings. Acta Radiol. Mar 2007;48(2):125-34. [Medline].

  9. Boulanger D, Dieng Y, Cisse B, Remoue F, Capuano F, Dieme JL. Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks. Trans R Soc Trop Med Hyg. Feb 2007;101(2):113-6. [Medline].

  10. Chitsulo L, Loverde P, Engels D. Schistosomiasis. Nat Rev Microbiol. Jan 2004;2(1):12-3. [Medline].

  11. Cioli D, Pica-Mattoccia L. Praziquantel. Parasitol Res. Jun 2003;90 Supp 1:S3-9. [Medline].

  12. Fenwick A, Webster JP. Schistosomiasis: challenges for control, treatment and drug resistance. Curr Opin Infect Dis. Dec 2006;19(6):577-82. [Medline].

  13. Franco-Paredes C, Rouphael N, Mendez J, Folch E, Rodriguez-Morales AJ, Santos JI. Cardiac manifestations of parasitic infections part 3: pericardial and miscellaneous cardiopulmonary manifestations. Clin Cardiol. Jun 2007;30(6):277-80. [Medline].

  14. Friedman JF, Mital P, Kanzaria HK, Olds GR, Kurtis JD. Schistosomiasis and pregnancy. Trends Parasitol. Apr 2007;23(4):159-64. [Medline].

  15. Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. Sep 23 2006;368(9541):1106-18. [Medline].

  16. Hayashi M. Clinical features of cerebral schistosomiasis, especially in cerebral and hepatosplenomegalic type. Parasitol Int. Dec 2003;52(4):375-83. [Medline].

  17. Hochberg N, Ryan ET. Medical problems in the returning expatriate. Clin Occup Environ Med. Feb 2004;4(1):205-19. [Medline].

  18. Jauréguiberry S, Ansart S, Perez L, Danis M, Bricaire F, Caumes E. Acute neuroschistosomiasis: two cases associated with cerebral vasculitis. Am J Trop Med Hyg. May 2007;76(5):964-6. [Medline].

  19. Khurana S, Dubey ML, Malla N. Association of parasitic infections and cancers. Indian J Med Microbiol. Apr 2005;23(2):74-9. [Medline].

  20. Loukas A, Tran M, Pearson MS. Schistosome membrane proteins as vaccines. Int J Parasitol. Mar 2007;37(3-4):257-63. [Medline].

  21. Magnussen P. Treatment and re-treatment strategies for schistosomiasis control in different epidemiological settings: a review of 10 years' experiences. Acta Trop. May 2003;86(2-3):243-54. [Medline].

  22. Martínez S, Restrepo CS, Carrillo JA, Betancourt SL, Franquet T, Varon C. Thoracic manifestations of tropical parasitic infections: a pictorial review. Radiographics. Jan-Feb 2005;25(1):135-55. [Medline].

  23. Meltzer E, Artom G, Marva E, Assous MV, Rahav G, Schwartzt E. Schistosomiasis among travelers: new aspects of an old disease. Emerg Infect Dis. Nov 2006;12(11):1696-700. [Medline].

  24. Moudgil A, Kosut J. Urinary schistosomiasis: an uncommon cause of gross hematuria in the industrialized countries. Pediatr Nephrol. Aug 2007;22(8):1225-7. [Medline].

  25. Pearce EJ. Progress towards a vaccine for schistosomiasis. Acta Trop. May 2003;86(2-3):309-13. [Medline].

  26. Ribeiro-dos-Santos G, Verjovski-Almeida S, Leite LC. Schistosomiasis--a century searching for chemotherapeutic drugs. Parasitol Res. Oct 2006;99(5):505-21. [Medline].

  27. Richens J. Genital manifestations of tropical diseases. Sex Transm Infect. Feb 2004;80(1):12-7. [Medline].

  28. Rollinson D, Simpson AJG, eds. The Biology of Schistosomes From Genes to Latrines. London: Academic Press; 1987.

  29. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, et al. Schistosomiasis. N Engl J Med. Apr 18 2002;346(16):1212-20. [Medline].

  30. Ross AG, Vickers D, Olds GR, Shah SM, McManus DP. Katayama syndrome. Lancet Infect Dis. Mar 2007;7(3):218-24. [Medline].

  31. Scrimgeour EM, Gajdusek DC. Involvement of the central nervous system in Schistosoma mansoni and S. haematobium infection. A review. Brain. Dec 1985;108 (Pt 4):1023-38. [Medline].

  32. Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol. Feb-Mar 2007;85(2):148-54. [Medline].

  33. Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev. Oct 2004;201:156-67. [Medline].

  34. Xu LN, Zou SQ. A clinicopathological analysis in unsuspected gallbladder carcinoma: a report of 23 cases. World J Gastroenterol. Mar 28 2007;13(12):1857-60; discussion 1860-1. [Medline].

Further Reading

Keywords

schistosomiasis, bilharziasis, bilharzia, bilharziosis, snail fever, parasitic trematodeshuman schistosomiasis, Schistosoma haematobium, S haematobium, Schistosoma mansoni, S mansoni, Schistosoma japonicum, S japonicum, Schistosoma mekongi, S mekongi, Schistosoma intercalatum, S intercalatum, schistosomes, swimmer’s itch, dermatitis, schistosomal infections, acute schistosomiasis, chronic schistosomiasis, Katayama fever, cercarial dermatitis

Contributor Information and Disclosures

Author

Amy J Behrman, MD, Associate Professor, Department of Emergency Medicine, Director, Division of Occupational Medicine, University of Pennsylvania School of Medicine
Amy J Behrman, MD is a member of the following medical societies: American College of Occupational and Environmental Medicine, American College of Physicians-American Society of Internal Medicine, American Public Health Association, Phi Beta Kappa, and Sigma Xi
Disclosure: Nothing to disclose.

Medical Editor

Joseph A Salomone, III, MD, Associate Professor, Department of Emergency Medicine, Truman Medical Center, University of Missouri at Kansas City School of Medicine
Joseph A Salomone, III, MD is a member of the following medical societies: American Academy of Emergency Medicine, Society for Academic Emergency Medicine, and Southern Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Jeter (Jay) Pritchard Taylor III, MD, Compliance Officer, Attending Physician Emergency Medicine Residency, Department of Emergency Medicine, Palmetto Richland Memorial Hospital, University of South Carolina
Jeter (Jay) Pritchard Taylor III, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Robert E O'Connor, MD, MPH, Professor and Chair, Department of Emergency Medicine, University of Virginia Health System
Robert E O'Connor, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Physician Executives, American Heart Association, American Medical Association, Medical Society of Delaware, National Association of EMS Physicians, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.